Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

NCT01850212 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT01850212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
October 31, 2014
Enrollment
476 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections